Félix Reyes

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text

Medicine, Immunology, Oncology +9

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

Corinne Haïoun, Emmanuel Itti, Alain Rahmouni et al. · Blood · 2005 · 497 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

James M. Foran, A. Z. S. Rohatiner, David Cunningham et al. · Journal of Clinical Oncology · 2000 · 475 citations

Medicine, Hematology, Oncology +14

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Corinne Haïoun, Éric Lepage, Christian Gisselbrecht et al. · Journal of Clinical Oncology · 2000 · 422 citations

Medicine, Oncology, Chemotherapy +15

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

Colette Adida, Corinne Haïoun, Philippe Gaulard et al. · PubMed · 2000 · 360 citations

Veterinary Medicine, Oncology, Pathology +11